Flash FinanceUS
Pre-market S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · Zoetis (ZTS)

Zoetis Q4 revenue rises 5% to $2.3 billion; 2025 EPS guidance $5.70 to $5.80

Positive Impact 3 of 5 earnings Written later

Zoetis reported fourth quarter and full year 2024 results and issued full year 2025 guidance. Fourth quarter revenue was $2.3 billion, up 5%, and full year revenue was $9.3 billion, up 8%, with reported diluted EPS of $5.47 for the year. For 2025, the company expects revenue of $9.225 billion to $9.375 billion and reported diluted EPS of $5.70 to $5.80, or adjusted diluted EPS of $6.00 to $6.10.

Key points

  • Fourth quarter 2024 net income was $581 million, or $1.29 per diluted share, up 11% and 13% on a reported basis.
  • Full year 2024 revenue was $9.3 billion, up 8%, and net income was $2.5 billion, or $5.47 per diluted share.
  • 2025 guidance: revenue of $9.225 billion to $9.375 billion; reported diluted EPS of $5.70 to $5.80; adjusted diluted EPS of $6.00 to $6.10.
  • The medicated feed additive portfolio divestiture was completed on October 31, 2024.

The filing

CompanyZoetis (ZTS)
Form8-K, current report
Filed with the SECFeb 13, 2025, 7:07 AM ET
Accession number0001555280-25-000100

Items reported: 2.02 Results of Operations

Read the filing on SEC.gov ↗

Written by AI on Nov 8, 2026, 1:30 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on February 13, 2025.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.